MSF Field Research >
1 Published Research and Commentary >
Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.
this identifier to cite or link
to this item:
|Download this article:|
|18 . Issikidas P et al MDR TB side effects PlosOne.pdf||86Kb||Adobe PDF|
|Title: ||Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.|
|Affiliation: ||Médecins Sans Frontières, Mumbai, India.|
|Citation: ||Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. 2012, 7 (7):e40781 PLoS ONE|
|Journal: ||PloS One|
|Issue Date: ||Jul-2012 |
|PubMed ID: ||22792406|
|Abstract: ||Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.|
|Rights: ||Published by Public Library of Science, http://www.plosone.org/
Archived on this site by Open Access permission|
|Appears in topics: ||TB|
|Related articles on PubMed|
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.
Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, Mansoor H, Ladomirska J, Sotgiu G, Migliori GB, Pontali E, Saranchuk P, Rodrigues C, Reid T
High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India.
Andries A, Isaakidis P, Das M, Khan S, Paryani R, Desai C, Dalal A, Mansoor H, Verma R, Fernandes D, Sotgiu G, Migliori GB, Saranchuk P
|See all 230 articles|
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.